Association between hematoma expansion severity and outcome and its interaction with baseline intracerebral hemorrhage volume

A Morotti, G Boulouis, J Nawabi, Q Li, A Charidimou… - Neurology, 2023 - AAN Enterprises
Background and Objectives Hematoma expansion (HE) is a major determinant of neurologic
deterioration and poor outcome in intracerebral hemorrhage (ICH) and represents an …

Atrial fibrillation in spontaneous intracerebral hemorrhage, Dijon Stroke Registry (2006–2017)

A Gabet, V Olié, Y Béjot - Journal of the American Heart …, 2021 - Am Heart Assoc
Background Atrial fibrillation (AF) represents a major indication for oral anticoagulants
(OAC) that contribute to spontaneous intracerebral hemorrhage (ICH). This study evaluated …

Hematoma expansion in intracerebral hemorrhage with unclear onset

A Morotti, G Boulouis, A Charidimou, Q Li, L Poli… - Neurology, 2021 - AAN Enterprises
Objective To investigate the prevalence, predictors, and prognostic effect of hematoma
expansion (HE) in patients with intracerebral hemorrhage (ICH) with unclear symptom onset …

Intensive blood pressure lowering in patients with moderate to severe grade acute cerebral hemorrhage: post hoc analysis of antihypertensive treatment of acute …

AI Qureshi, LD Foster, I Lobanova, W Huang… - Cerebrovascular …, 2020 - karger.com
Objective: To study the effect of intensive blood pressure reduction in patients with moderate
to severe intracerebral hemorrhage (ICH) within the subjects recruited in Antihypertensive …

[HTML][HTML] Exploring hematoma expansion shift with recombinant factor VIIa: a pooled analysis of 4 randomized controlled trials

V Yogendrakumar, SA Mayer, T Steiner, JP Broderick… - Stroke, 2023 - journals.lww.com
BACKGROUND: Hematoma expansion shift (HES) analysis can be used to assess the
biological effect of a hemostatic therapy for intracerebral hemorrhage. In this study, we …

Noncontrast computed tomography markers of cerebral hemorrhage expansion: diagnostic accuracy meta-analysis

F Arba, C Rinaldi, G Boulouis… - … Journal of Stroke, 2022 - journals.sagepub.com
Background and purpose Assess the diagnostic accuracy of noncontrast computed
tomography (NCCT) markers of hematoma expansion in patients with primary intracerebral …

The frequency of imaging markers adjusted for time since symptom onset in intracerebral hemorrhage: a novel predictor for hematoma expansion

L Song, J Cheng, C Zhang, H Zhou… - … Journal of Stroke, 2024 - journals.sagepub.com
Background: Hematoma expansion (HE) is common in patients with intracerebral
hemorrhage (ICH) and associated with a worse outcome. Imaging makers and shorter time …

Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind …

N Yassi, H Zhao, L Churilov, TY Wu, H Ma… - The Lancet …, 2024 - thelancet.com
Background Tranexamic acid, an antifibrinolytic agent, might attenuate haematoma growth
after an intracerebral haemorrhage. We aimed to determine whether treatment with …

Effects of Achieving Rapid, Intensive, and Sustained Blood Pressure Reduction in Intracerebral Hemorrhage Expansion and Functional Outcome

D Rodriguez-Luna, O Pancorbo, L Llull, Y Silva… - Neurology, 2024 - AAN Enterprises
Background and Objectives The time taken to achieve blood pressure (BP) control could be
pivotal in the benefits of reducing BP in acute intracerebral hemorrhage (ICH). We aimed to …

An 18-month single-center observational study of real-world use of andexanet alfa in patients with factor Xa inhibitor associated intracranial hemorrhage

A Giovino, E Shomo, KV Busey, D Case… - Clinical Neurology and …, 2020 - Elsevier
Objective Intracranial hemorrhage is a life threatening complication of factor Xa inhibitors.
Except for results of the open-label, single-arm ANNEXA-4 study, published real-world …